Related Experiment Video

Updated: Aug 16, 2026

Investigating the Phagocytosis of Leishmania using Confocal Microscopy
08:41

Investigating the Phagocytosis of Leishmania using Confocal Microscopy

Published on: July 29, 2021

Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages

Jean-François Dermine1, Guillaume Goyette, Mathieu Houde

  • 1Département de Pathologie et Biologie Cellulaire, Université de Montréal, C. P. 6128, Succ. Centre ville, Montreal, H3C 3J7, Canada.

Cellular Microbiology
|August 16, 2005
PubMed

Insights

Leishmania parasites survive in macrophages by disrupting phagosome membranes. Their surface lipophosphoglycan (LPG) prevents the formation of essential lipid microdomains, aiding parasite survival.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Phagocytosis is crucial for innate immunity, but pathogens like Leishmania evade it.
  • Leishmania parasites survive within macrophages by blocking phagosome maturation and avoiding lysosomal killing.

Purpose of the Study:

  • To investigate the mechanism by which Leishmania donovani evades host defenses within macrophages.
  • To elucidate the role of Leishmania surface lipophosphoglycan (LPG) in parasite survival.

Main Methods:

  • Analysis of phagosome maturation and lipid microdomain organization in macrophages infected with Leishmania donovani.
  • Investigating the function of Leishmania LPG, particularly its carbohydrate moieties, in membrane disruption.

Main Results:

  • Leishmania donovani utilizes its surface lipophosphoglycan (LPG) as a virulence factor.
  • LPG prevents the formation or disrupts lipid microdomains on the phagosome membrane.
  • The repetitive carbohydrate structures of LPG are essential for altering microdomain organization.

Conclusions:

  • Leishmania donovani employs a novel strategy involving LPG to disrupt phagosome membrane organization.
  • Disruption of functional foci in phagolysosome biogenesis provides a survival advantage to the parasite.
  • Targeting LPG could be a potential therapeutic strategy against Leishmania infections.

More Related Videos

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...